NORTHERN TRUST CORP - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 42 filers reported holding EVELO BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$17,045
-88.9%
94,330
-0.7%
0.00%
Q4 2022$152,902
-23.2%
94,970
-0.3%
0.00%
Q3 2022$199,000
+30.9%
95,272
+32.1%
0.00%
Q2 2022$152,000
-84.4%
72,135
-74.9%
0.00%
Q1 2022$973,000
-46.7%
286,971
-4.5%
0.00%
Q4 2021$1,824,000
-13.1%
300,436
+0.8%
0.00%
Q3 2021$2,100,000
-52.6%
298,136
-7.6%
0.00%
-100.0%
Q2 2021$4,433,000
+62.6%
322,651
+26.6%
0.00%0.0%
Q1 2021$2,727,000
-1.2%
254,880
+11.7%
0.00%0.0%
Q4 2020$2,759,000
+134.4%
228,170
+2.1%
0.00%
Q3 2020$1,177,000
+38.3%
223,368
+28.6%
0.00%
Q2 2020$851,000
+51.7%
173,639
+16.1%
0.00%
Q1 2020$561,000
-1.1%
149,506
+7.1%
0.00%
Q4 2019$567,000
-33.1%
139,641
+0.5%
0.00%
Q3 2019$847,000
-32.2%
138,991
-0.2%
0.00%
Q2 2019$1,250,000
+14.1%
139,200
+1.6%
0.00%
Q1 2019$1,096,000
-34.3%
136,998
+6.9%
0.00%
Q4 2018$1,667,000
+134.5%
128,155
+119.7%
0.00%
Q3 2018$711,000
+213.2%
58,330
+203.1%
0.00%
Q2 2018$227,00019,2470.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders